CL2-95014-002-laysummary-2023.05.06_RU

Home » A Multicentre, Phase II Randomized Study, Open-label, With 2-arm Parallel Group, Comparing the Pharmacokinetics of the Liquid and the Lyophilized Formulations of Pegaspargase (S95014) in Treatment of Paediatric Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) » CL2-95014-002-laysummary-2023.05.06_RU

© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.

Accessibility